Accelerating Drug Discovery for FTD RFP
Funds early translational drug discovery for frontotemporal degeneration globally.
About
The Accelerating Drug Discovery for FTD RFP supports frontotemporal degeneration drug discovery through a joint ADDF-AFTD route. It sits within ADDF's broader Alzheimer's and dementia funding platform but is focused on FTD rather than Alzheimer's disease alone.
The program uses grant funding, is annual, and is open globally to for-profit companies, nonprofits, universities, and research organizat…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.